» Authors » Marcel Peltier

Marcel Peltier

Explore the profile of Marcel Peltier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 407
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Donal E, Dreyfus J, Leurent G, Coisne A, Leroux P, Ganivet A, et al.
JAMA . 2024 Nov; 333(2):124-132. PMID: 39602173
Importance: Correction of tricuspid regurgitation using tricuspid transcatheter edge-to-edge repair (T-TEER) in addition to guideline-directed optimized medical therapy (OMT) may improve clinical outcomes. Objective: To evaluate the efficacy of T-TEER ...
2.
Tribouilloy C, Bohbot Y, Marechaux S, Debry N, Delpierre Q, Peltier M, et al.
Circ Cardiovasc Imaging . 2016 Dec; 9(11). PMID: 27903539
Background: Current guidelines define severe aortic stenosis in patients with aortic valve area normalized to body surface area (AVA/BSA) <0.6 cm/m; yet, this cutoff has never been validated. Moreover, it...
3.
Debry N, Marechaux S, Rusinaru D, Peltier M, Messika-Zeitoun D, Menet A, et al.
Arch Cardiovasc Dis . 2016 Nov; 110(1):26-34. PMID: 27839677
Background: Four patterns of left ventricular (LV) geometry (normal, concentric remodelling, concentric hypertrophy and eccentric hypertrophy) have been described in aortic stenosis (AS). Although LV concentric remodelling (LVCR), characterized by...
4.
Levy F, Rusinaru D, Marechaux S, Charles V, Peltier M, Tribouilloy C
Am J Cardiol . 2015 Sep; 116(10):1541-6. PMID: 26410605
Atrial fibrillation (AF) is frequently encountered in patients with aortic stenosis (AS) and its incidence also increases with age. In the general population, AF is known to increase cardiovascular risk....
5.
Levy F, Fayad N, Jeu A, Choquet D, Szymanski C, Malaquin D, et al.
Arch Cardiovasc Dis . 2014 Sep; 107(10):519-28. PMID: 25240605
Background: Risk stratification in asymptomatic patients with severe aortic stenosis (AS) is based on exercise test results. However, differentiating between pathological and physiological breathlessness during exercise is sometimes challenging. Cardiopulmonary...
6.
Szymanski C, Andrejak M, Peltier M, Marechaux S, Tribouilloy C
Pharmacoepidemiol Drug Saf . 2014 May; 23(7):679-86. PMID: 24817577
Benfluorex is responsible for the development of restrictive valvular regurgitation due to one of its metabolites, norfenfluramine. The 5-HT2B receptor, expressed on heart valves, acts as culprit receptor for drug-induced...
7.
Buiciuc O, Rusinaru D, Levy F, Peltier M, Slama M, Leborgne L, et al.
J Card Fail . 2011 Nov; 17(11):907-15. PMID: 22041327
Background: Systolic blood pressure (SBP) at hospital admission predicts in-hospital and postdischarge mortality in patients with left ventricular systolic dysfunction. The relationship between admission SBP and mortality in heart failure...
8.
Tribouilloy C, Rusinaru D, Szymanski C, Mezghani S, Fournier A, Levy F, et al.
Eur J Echocardiogr . 2011 Aug; 12(9):702-10. PMID: 21821606
Aims: Left ventricular (LV) dysfunction is the first cause of late mortality after mitral valve surgery. In this retrospective analysis, we studied the association between preoperative echocardiographic LV measures and...
9.
Guendouz S, Buicuic O, Kirsch M, Benaiem N, Poulard J, Deux J, et al.
J Am Coll Cardiol . 2011 Apr; 57(15):1633. PMID: 21474043
No abstract available.
10.
Fournier A, Touati G, Renard C, Peltier M
Eur J Cardiothorac Surg . 2010 Sep; 39(4):606. PMID: 20850336
No abstract available.